Sort
34,240 grants matching “atherosclerosis”
Treatment of choroidal subretinal neovascularization with immune agents
$396,762Robert B. Nussenblatt · National Eye Institute · Z01 · FY2008 · EY
Apolipoprotein conformation in amyloid and cardiovascular diseases
$396,753Olga Gursky · Boston University Medical Campus · R01 · FY2017 · GM
Signature Protein Profiles to Identify AAAs
$396,746Philip S Tsao · Stanford University · P50 · FY2007 · HL
FUNCTIONAL GENOMICS OF ARTERIAL THROMBOSIS
$396,716University Of Texas Hlth Sci Ctr Houston · R01 · FY2000 · NS
The role of protease-activated receptor 2 (PAR2) in the pathogenesis of Alzheimerâs Disease (AD)
$396,631Albert Phillip Owens III · University Of Cincinnati · R01 · FY2019 · HL
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM
$396,629Jeffrey D Esko · University Of California, San Diego · R37 · FY2008 · GM
SREBP pathway and cellular cholesterol homeostasis
$396,615University Of Texas Sw Med Ctr/Dallas · P01 · FY2005 · HL
11/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
$396,614David M Nathan · Massachusetts General Hospital · U01 · FY2020 · DK
Role of the Granzyme B Pathway in AGA
$396,562Antony Rosen · Johns Hopkins University · P01 · FY2007 · HL
SCAVANGER RECEPTOR-LIGAND BINDING AND PATHOPHYSIOLOGY
$396,545Massachusetts Institute Of Technology · R01 · FY2001 · HL
NEW FACULTY RECRUITMENT IMAGE-GUIDED CANCER THERAPEUTICS
$396,513Jeffrey L. Duerk · Case Western Reserve University · P30 · FY2010 · EB
Avoiding toxicity associated with MTP ablation
$396,458M Mahmood Hussain · Suny Downstate Medical Center · R01 · FY2010 · HL
MR imaging of myeloperoxidase activity
$396,406Massachusetts General Hospital · R01 · FY2004 · HL
ACE Inhibition and Novel Cardiovascular Risk Factors
$396,359University Of Florida · R01 · FY2004 · HL
Class B Scavenger Receptor, CD36, in Atherosclerosis
$396,354Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2004 · HL
Monocyte Subsets & Immunity in Mouse and Human Atherosclerosis
$396,340Catherine C Hedrick · La Jolla Institute For Immunology · P01 · FY2019 · HL
Monocyte Subsets & Immunity in Mouse and Human Atherosclerosis
$396,340Catherine C Hedrick · La Jolla Institute For Immunology · P01 · FY2020 · HL
Monocyte Subsets & Immunity in Mouse and Human Atherosclerosis
$396,333Catherine C Hedrick · La Jolla Institute For Immunology · P01 · FY2018 · HL
Regulation Microvascular Smooth Muscle Ca2+ & BK+ ECM-Integrin-Cytoskeletal Axis
$396,332Michael John Davis · University Of Missouri-Columbia · P01 · FY2012 · HL
Regulation of Cell Adhesions by Mechanical Force
$396,319Tamara C Bidone · University Of Utah · · FY2021 · ENG
Cardiovascular disease (CVD) and the endothelial bone marrow niche: Project 2
$396,317Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2019 · HL
Role of WRN in Longevity Assurance
$396,291University Of Calif-Lawrenc Berkeley Lab · R01 · FY2005 · AG
Novel Targets of Rapamycin & Akt in VSMC Differentiation
$396,270Kathleen Ann Martin · Yale University · R01 · FY2013 · HL
Phosphorylation and Endothelial Nitric Oxide Production
$396,270William C. Sessa · Yale University · R01 · FY2013 · HL
Project 3: Plasminogen and Plasminogen Receptors in Inflammation and CVD
$396,251Edward Franklin Plow · Cleveland Clinic Lerner Com-Cwru · P01 · FY2017 · HL